XRAYXRAYHealthcare · Medical Instruments & Supplies

XRAY Stock Forecast: Dentsply Sirona, Inc. Price Predictions for 2026-2027

Last close, 20 Nov 2026
$8.29
−2.41% on the day

The 17 Wall Street analysts covering Dentsply Sirona, Inc. hold a median 12-month price target of $11 — +32.8% from the last close. Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 78 of 100 as at 21 Nov 2026 — inside the top quartile. Here, the model and the Street point the same way.

Market cap
$1.7B
Ticker Nerd rank
78/ 100
Median analyst target
$11
Analysts covering
17
Revenue$898.0M−4.1% y/y
Operating income$83.0M
Net income$36.0M
Free cash flow$55.0M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−9.6%
1M
−6.6%
YTD
−27.5%
1Y
−15.1%
From 52W high
−43.6%
From 52W low
0.0%
$8
$15
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

One number for the whole business

Consensus tells you what everyone already believes. The model scores Dentsply Sirona, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 21 Nov 2026
78/ 100

Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Value
97
Issuance
96
Volatility
85
Accruals
81
Growth
70
Quality
59
Momentum
37
Revisions
29

Value (97): The shares cost little relative to the profits and assets behind them — which can mean the market is too gloomy, or that the business really is in trouble.

Revisions (29): Analysts have, on balance, been cutting their forecasts.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

XRAY stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on XRAY, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$8$10$12$14Jan 26Apr 26Jul 26Oct 26XRAYHigh $14Median $11Low $8

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says17 analysts
4
Buy
12
Hold
1
Sell
$8
Low
$11
Median
$14
High

The green dot is the last close — the median target sits +32.8% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 2 moved their price target up and 7 moved it down.

DateFirmActionRatingTarget
16 Nov 2026UBSMaintainsBuy$17 → $13
7 Nov 2026JP MorganMaintainsNeutral—
6 Nov 2026JP MorganMaintainsNeutral$12 → $10
26 Oct 2026Barrington ResearchMaintainsOutperform$15 → $13
22 Oct 2026MizuhoMaintainsNeutral$14 → $12
14 Oct 2026Leerink PartnersMaintainsMarket Perform$14 → $10
9 Oct 2026Piper SandlerMaintainsNeutral$14 → $12
17 Sept 2026BMO CapitalMaintainsMarket Perform$13 → $10
24 Aug 2026BarclaysMaintainsUnderweight$9.00 → $11
29 July 2026Piper SandlerMaintainsNeutral$13 → $14
9 July 2026BMO CapitalInitiatesMarket Perform—
4 June 2026BarclaysMaintainsUnderweight—
7 May 2026UBSMaintainsBuy—
6 May 2026MizuhoMaintainsNeutral—
15 Apr 2026CitigroupInitiatesSell—
2 Mar 2026Barrington ResearchMaintainsOutperform—
2 Mar 2026MizuhoMaintainsNeutral—
27 Feb 2026BairdMaintainsNeutral—
27 Feb 2026Evercore ISI GroupMaintainsIn-Line—
27 Feb 2026Wells FargoMaintainsEqual-Weight—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Wall Street targets run 12 to 18 months out. No analyst publishes a 2030 price target for XRAY.

Market Radar

This page is one stock. Monday covers all of them.

XRAY appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.

Free. Unsubscribe any time. Privacy

The AI build-out map
PDF
  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and servers

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Performance

XRAY vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 20 Nov 2026, Dentsply Sirona, Inc. returned −15.1% against +6.9% for the S&P 500, dividends included.

XRAY vs S&P 500, last 12 monthsTotal return, rebased to 100
8090100110120130140150Jan 26Apr 26Jul 26Oct 26XRAYS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

XRAY analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingThis fiscal year
EPS revision, 90 days
−12.1%
Analysts raising
0
Analysts cutting
11
Fundamentals

Financials

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
—
Price / sales
0.5×

Cheaper than 80% of US stocks

Price / book
1.2×

Cheaper than 64% of US stocks

EV / EBITDA
7.4×

Cheaper than 71% of US stocks

Growth & margins
Revenue growth (YoY)
−7.5%

Higher than 18% of US stocks

Earnings growth (YoY)
—
Gross margin
54.9%

Higher than 68% of US stocks

Operating margin
4.7%

Higher than 52% of US stocks

Net margin
—
Returns & dividend
Return on equity
−8.6%

Higher than 37% of US stocks

Return on assets
1.9%

Higher than 57% of US stocks

Dividend yield
7.7%

Higher than 87% of US dividend payers

Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.

Statistics

Key statistics

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Dentsply Sirona, Inc. has a market value of $1.7B and an enterprise value of $3.8B.

  • Revenue in the twelve months to 30 June 2026: $3.6B. The latest quarter shrank 4.1% year on year.

  • Net income over the same four quarters: −$547.0M, a −15.0% net margin.

  • Diluted earnings per share, trailing twelve months: −$2.75.

  • Free cash flow in the twelve months to 30 June 2026: $143.0M, after $176.0M of capital spending.

  • Dentsply Sirona, Inc. spent $96.0M on dividends in the twelve months to 30 June 2026.

  • Shares outstanding: 199.2M.

  • forward P/E: 6.8× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 7.72%.

  • Dentsply Sirona, Inc. employs 14,000 people — $260K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 21 Nov 2026

Data provided by Twelve Data

Peers

XRAY and its peers

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Instruments & Supplies
CompanyMarket capTKN rank
XRAYDentsply Sirona, Inc.$1.7B78
LMATLeMaitre Vascular, Inc.$1.7B69
AZTAAzenta, Inc.$1.9B96
KMTSKestra Medical Technologies Ltd.$1.4B27
STAASTAAR Surgical Co.$1.2B89
ATRCAtriCure, Inc.$2.8B94
WRBYWarby Parker, Inc.$2.9B28

Take a look at XRAY’s peer groups, ranked by the model: healthcare stocks.

Look up any of the roughly 4,300 stocks we score.

The rank is the raw material. Whether the rules would actually own Dentsply Sirona, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

FAQ

Questions about XRAY

What is the XRAY stock price forecast for 2026-2027?

The 17 Wall Street analysts covering Dentsply Sirona, Inc. have a median 12-month price target of $11, with estimates ranging from $8 to $14. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is XRAY stock a buy right now?

Of the 17 analysts covering Dentsply Sirona, Inc., 4 rate it a Buy, 12 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Dentsply Sirona, Inc. 78 out of 100 across roughly 4,300 US stocks as at 21 Nov 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank XRAY?

As at 21 Nov 2026, Dentsply Sirona, Inc. ranks 78 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Value (97 of 100).

Will XRAY stock go up?

No one can know that. What the data says: the median 12-month target from 17 analysts implies +32.8% from the last close, and Ticker Nerd's factor model ranks Dentsply Sirona, Inc. 78 out of 100 as at 21 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the XRAY stock forecast for 2030?

No analyst covering Dentsply Sirona, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for XRAY are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $8 to $14 over the next 12 months.

How has XRAY stock performed over the past year?

Dentsply Sirona, Inc. returned -15.1% over the 12 months to 20 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Dentsply Sirona, Inc. do?

Dentsply Sirona Inc. is a global dental products and technologies company that serves dental practices, clinics, laboratories, and distributors worldwide. The company develops, manufactures, and markets a broad portfolio that includes dental consumables, restorative materials, digital imaging systems, CAD/CAM restoration platforms, treatment centers, handpieces, hygiene systems, orthodontic and implant products, and specialty solutions for endodontics and other oral care applications.

Company

About Dentsply Sirona, Inc.

Dentsply Sirona Inc. is a global dental products and technologies company that serves dental practices, clinics, laboratories, and distributors worldwide. The company develops, manufactures, and markets a broad portfolio that includes dental consumables, restorative materials, digital imaging systems, CAD/CAM restoration platforms, treatment centers, handpieces, hygiene systems, orthodontic and implant products, and specialty solutions for endodontics and other oral care applications. Dentsply Sirona also provides workflow-oriented technologies designed to support diagnosis, treatment planning, and chairside procedures across modern dental settings. Headquartered in Charlotte, North Carolina, Dentsply Sirona is a major supplier in the professional dental market, combining equipment, software-enabled tools, and everyday consumables to support clinical efficiency and patient care.

CEO Mr. Daniel T. Scavilla · 14,000 employees · United States · https://www.dentsplysirona.com